Success Metrics

Clinical Success Rate
85.7%

Based on 12 completed trials

Completion Rate
86%(12/14)
Active Trials
1(6%)
Results Posted
33%(4 trials)
Terminated
2(12%)

Phase Distribution

Ph phase_2
1
6%
Ph not_applicable
5
29%
Ph phase_3
1
6%
Ph phase_1
2
12%

Phase Distribution

2

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
2(22.2%)
Phase 2Efficacy & side effects
1(11.1%)
Phase 3Large-scale testing
1(11.1%)
N/ANon-phased studies
5(55.6%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

80.0%

12 of 15 finished

Non-Completion Rate

20.0%

3 ended early

Currently Active

1

trials recruiting

Total Trials

17

all time

Status Distribution
Active(1)
Completed(12)
Terminated(3)
Other(1)

Detailed Status

Completed12
Terminated2
Recruiting1
Withdrawn1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
17
Active
1
Success Rate
85.7%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (22.2%)
Phase 21 (11.1%)
Phase 31 (11.1%)
N/A5 (55.6%)

Trials by Status

terminated212%
recruiting16%
withdrawn16%
completed1271%
unknown16%

Recent Activity

1 active trials
Showing 5 of 17
recruiting

Transfusion Surveillance in Anaesthesia

NCT06403163
completedphase_2

Age of Blood in Sickle Cell Transfusion

NCT03704922
completed

AutoTransfusion Versus TRAnsfusion in Cancer Surgery

NCT05452538
completedphase_1

Extracorporeal Photopheresis of Patients With Crohn's Disease Using 5-aminolevulinic Acid

NCT04164849
unknownnot_applicable

Myocardial Ischemia and Transfusion

NCT02619136
View all 17 trials

Clinical Trials (17)

Showing 17 of 17 trials
NCT06403163

Transfusion Surveillance in Anaesthesia

Recruiting
NCT03704922Phase 2

Age of Blood in Sickle Cell Transfusion

Completed
NCT05452538

AutoTransfusion Versus TRAnsfusion in Cancer Surgery

Completed
NCT04164849Phase 1

Extracorporeal Photopheresis of Patients With Crohn's Disease Using 5-aminolevulinic Acid

Completed
NCT02619136Not Applicable

Myocardial Ischemia and Transfusion

Unknown
NCT00003138Phase 3

Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes

Completed
NCT03643042Not Applicable

Impact of 2 Transfusion Strategies on Quality of Life of Multitransfused Patients With Low-risk Myelodysplastic Syndrome

Terminated
NCT03397017

Transfusion Treatment in Patients With SCD

Completed
NCT05661838

Effect of Intraoperative Allogeneic Blood Transfusion on Postoperative Pulmonary Complications

Completed
NCT04194047

Effects of Red Blood Cells Transfusion on Renal Blood Flow

Completed
NCT04249193

Pulse Oximetry Measurement and Transfusions

Completed
NCT03282201

A Survey on Blood Transfusions in Major Artrhoplasty Operations

Completed
NCT00326924Not Applicable

Age of Red Blood Cells in Premature Infants Study (ARIPI)

Completed
NCT01534676Not Applicable

Effects of Transfusion of Older Stored Red Cells

Terminated
NCT02845232

Economic Analysis of Blood Product Transfusions According to the Treatment of Acute Myeloid Leukaemia in the Elderly

Completed
NCT00578045Phase 1

UARK 2006-28 Human Cord Blood Transplantation in Advanced Hematological Malignancies

Withdrawn
NCT01341002Not Applicable

Red Blood Cells (RBC) Transfusion Related to Central Venous O2 Saturation (ScvO2) Measurement

Completed

All 17 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
17